Cargando…
Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin-SN
Psoralen (PSO) exerts anti-inflammatory pharmacological effects and plays an important role in a variety of inflammatory diseases. However, the effects of PSO with allergic rhinitis (AR) are yet to be reported. In the present study, an in vitro AR model was generated by inducing JME/CF15 human nasal...
Autores principales: | Gao, Wenying, Jin, Zhenglong, Zheng, Yanxia, Xu, Youjia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299190/ https://www.ncbi.nlm.nih.gov/pubmed/34278468 http://dx.doi.org/10.3892/mmr.2021.12291 |
Ejemplares similares
-
Cystatin SN Upregulation in Patients with Seasonal Allergic Rhinitis
por: Imoto, Yoshimasa, et al.
Publicado: (2013) -
Nasal mucus proteome and its involvement in allergic rhinitis
por: Tomazic, Peter Valentin, et al.
Publicado: (2020) -
The (potential) role of apolipoproteins in nasal mucus of allergic rhinitis patients
por: Tomazic, Peter, et al.
Publicado: (2014) -
Diagnosis and management of nonallergic rhinitis with eosinophilia syndrome using cystatin SN together with symptoms
por: Meng, Yifan, et al.
Publicado: (2020) -
Anti-allergic and anti-inflammatory effects of resveratrol via inhibiting TXNIP-oxidative stress pathway in a mouse model of allergic rhinitis
por: Zhang, Weitian, et al.
Publicado: (2020)